You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

224 Results
Regimen
Cancer Type:
Gynecologic, 
Endometrial
Intent: Adjuvant, Curative, Palliative
Jun 2025
Regimen
Cancer Type:
Gynecologic, 
Endometrial
Intent: Adjuvant, Curative, Palliative
Jun 2025
Guidelines and Advice
Status: Current
ID: GL 2-33
Version: 2
Updated
Jun 2025
Drug
Other Name(s): Akeega™
Updated
Jul 2025
Guidelines and Advice
Updated
Mar 2025
Regimen
Cancer Type:
Gynecologic, 
Ovary
Intent: Palliative
Updated
Jul 2025
Guidelines and Advice
Status: Current
ID: 3-14
Version: 3
Updated
Jun 2025
Guidelines and Advice
Status: Current
ID: 4-16
Version: 3
Updated
May 2025
Drug
Other Name(s): Tecentriq® SC
Updated
Jul 2025
Drug
Other Name(s): Tecentriq™
Updated
Jul 2025
Drug
Other Name(s): Tasigna®
Updated
Jul 2025
Drug
Other Name(s): Cytosar®
Updated
Jul 2025

Pages